Analysis

Scancell Holdings Plc (SCP) Stock Analysis

Scancell Holdings Plc investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to SCP.

websiteSCP/analysis/SCP

Scancell Holdings Plc

Scancell Holdings Plc investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to SCP.

Stock profile

Ticker

SCP

Asset type

Stock

Market cap

$284.4M

Sector

Health Technology

Industry

Biotechnology

Currency

EUR

Ticker listings

Scancell Holdings Plc may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • SCLP primary listing
  • SCNLF
  • SCLP.GB
  • SCP primary listing

Latest Scancell Holdings Plc news

Scancell receives FDA Fast Track Designation for iSCIB1+ in advanced melanoma and provides data update from its SCOPE Phase 2 study

Potent and durable efficacy with iSCIB1+ of 77% progression free survival (PFS) at 20 months, in combination with ipilimumab and nivolumab, demonstrated in the Phase 2 SCOPE tri...

Scancell announces CFO transition

Scancell Holdings plc announced a CFO transition with David Schilansky appointed as financial advisor and interim CFO, effective immediately, to ensure continuity as the company...

Interim Results for the six months ended 31 October 2025

OXFORD, United Kingdom, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Scancell Holdings plc (AIM: SCLP), the developer of ImmunoBody® and Moditope® active immunotherapies to treat cancer, t...

Half-year Financial Report

Scancell Holdings plc reported interim results for the six months ended 31 October 2025, with an operating loss of £8.9 million, an improvement from £10.5 million in the prior y...

FDA clearance of IND application for iSCIB1+

Scancell Holdings plc announced that the FDA has cleared its Investigational New Drug application for a Phase 3 trial of iSCIB1+ in advanced melanoma, with progression-free surv...

Research sections

Valuation

Review valuation context for Scancell Holdings Plc.

Future growth

Review future growth context for Scancell Holdings Plc.

Past performance

Review past performance context for Scancell Holdings Plc.

Financial health

Review financial health context for Scancell Holdings Plc.

Dividend

Review dividend context for Scancell Holdings Plc.

Management

Review management context for Scancell Holdings Plc.

Ownership

Review ownership context for Scancell Holdings Plc.

Other information

Review other information context for Scancell Holdings Plc.

Community

Review community context for Scancell Holdings Plc.